1. Home
  2. YDKG vs SXTP Comparison

YDKG vs SXTP Comparison

Compare YDKG & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yueda Digital Holding Class A Ordinary Share

YDKG

Yueda Digital Holding Class A Ordinary Share

HOLD

Current Price

$0.89

Market Cap

4.8M

ML Signal

HOLD

Logo 60 Degrees Pharmaceuticals Inc.

SXTP

60 Degrees Pharmaceuticals Inc.

HOLD

Current Price

$1.69

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDKG
SXTP
Founded
2005
2010
Country
China
United States
Employees
17
3
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
4.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
YDKG
SXTP
Price
$0.89
$1.69
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.10
AVG Volume (30 Days)
138.5K
78.3K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$33.92
Revenue Next Year
N/A
$51.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.34
52 Week High
$3.90
$8.62

Technical Indicators

Market Signals
Indicator
YDKG
SXTP
Relative Strength Index (RSI) 47.17 63.98
Support Level $0.81 $1.29
Resistance Level $1.02 $1.84
Average True Range (ATR) 0.08 0.13
MACD 0.00 0.04
Stochastic Oscillator 24.70 87.72

Price Performance

Historical Comparison
YDKG
SXTP

About YDKG Yueda Digital Holding Class A Ordinary Share

Yueda Digital Holding is a digital-economy company with a focus on the long-term accumulation of mainstream cryptocurrencies. The business activities of the company include active treasury management of mainstream digital assets, exploration of compliant, risk-managed yield opportunities, such as staking, on-chain liquidity provision, and other conservative market activities, selective investments and partnerships in Web3 infrastructure and applications, and advisory services for enterprises entering the digital-asset economy.

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

Share on Social Networks: